Xenetic Biosciences Inc (XBIO) — Financial Flexibility Index
Xenetic Biosciences Inc (XBIO) has a Financial Flexibility Index of -0.59x as of September 2025. Free cash flow of $-658.24K (operating CF $-658.25K minus capex $3.00) represents -1% of total liabilities ($1.11 Million). Check Xenetic Biosciences Inc cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Xenetic Biosciences Inc Financial Flexibility Index (2012–2024)
Historical Financial Flexibility Index trend for Xenetic Biosciences Inc across 13 annual periods. For the full cash flow conversion analysis, see XBIO cash generation efficiency.
Annual Financial Flexibility Index for Xenetic Biosciences Inc (2012–2024)
Year-by-year free cash flow to debt coverage for Xenetic Biosciences Inc. Explore XBIO operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -3.15x | $-2.82 Million | $-2.82 Million | $894.26K | ▲ +38.0% |
| 2023 | -5.08x | $-4.11 Million | $-4.11 Million | $809.59K | ▼ -31.5% |
| 2022 | -3.86x | $-4.15 Million | $-4.65 Million | $1.07 Million | ▼ -15.9% |
| 2021 | -3.33x | $-4.74 Million | $-4.74 Million | $1.42 Million | ▲ +24.7% |
| 2020 | -4.43x | $-4.27 Million | $-4.27 Million | $963.97K | ▼ -199.8% |
| 2019 | -1.48x | $-6.40 Million | $-6.40 Million | $4.33 Million | ▼ -3.2% |
| 2018 | -1.43x | $-6.46 Million | $-6.46 Million | $4.52 Million | ▼ -562.7% |
| 2017 | 0.31x | $1.50 Million | $1.49 Million | $4.86 Million | ▲ +116.9% |
| 2016 | -1.83x | $-8.77 Million | $-8.79 Million | $4.80 Million | ▼ -254.8% |
| 2015 | -0.51x | $-5.30 Million | $-5.30 Million | $10.30 Million | ▲ +75.5% |
| 2014 | -2.10x | $-12.27 Million | $-12.33 Million | $5.84 Million | ▼ -141.1% |
| 2013 | -0.87x | $-5.97 Million | $-6.05 Million | $6.85 Million | ▲ +34.7% |
| 2012 | -1.34x | $-6.13 Million | $-6.26 Million | $4.59 Million | — |